H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Neuroscience H-index 112 Citations 54,688 427 World Ranking 174 National Ranking 113
Medicine H-index 120 Citations 65,250 581 World Ranking 1536 National Ranking 931

Research.com Recognitions

Awards & Achievements

2015 - Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases, American Academy of Neurology

2015 - Sedgwick Memorial Medal, American Public Health Association

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Alzheimer's disease
  • Disease

Reisa A. Sperling spends much of his time researching Alzheimer's disease, Neuroscience, Dementia, Disease and Cognition. His Alzheimer's disease research is multidisciplinary, incorporating elements of Biomarker, Neuroimaging and Cognitive decline. His Dementia research is multidisciplinary, incorporating perspectives in Gerontology, Predictive value of tests, Age of onset, PSEN1 and Amyloid.

His studies in Disease integrate themes in fields like Psychiatry, Clinical trial, Bioinformatics and Intensive care medicine. Reisa A. Sperling focuses mostly in the field of Cognition, narrowing it down to topics relating to Cohort study and, in certain cases, Executive dysfunction and Activities of daily living. His research integrates issues of Placebo and Oncology in his study of Internal medicine.

His most cited work include:

  • Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (4114 citations)
  • NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease (2145 citations)
  • Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease (2062 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Disease, Neuroscience, Internal medicine, Alzheimer's disease and Dementia. His study focuses on the intersection of Disease and fields such as Cognition with connections in the field of Clinical psychology, Audiology and Developmental psychology. As a member of one scientific family, Reisa A. Sperling mostly works in the field of Neuroscience, focusing on Amyloid and, on occasion, Positron emission tomography.

His biological study spans a wide range of topics, including Endocrinology and Oncology. His Alzheimer's disease research includes themes of Magnetic resonance imaging and Neuroimaging. His research in Dementia focuses on subjects like Gerontology, which are connected to Activities of daily living.

He most often published in these fields:

  • Disease (43.50%)
  • Neuroscience (38.92%)
  • Internal medicine (36.00%)

What were the highlights of his more recent work (between 2018-2021)?

  • Disease (43.50%)
  • Internal medicine (36.00%)
  • Cognitive decline (28.62%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Disease, Internal medicine, Cognitive decline, Cognition and Amyloid. His work in Disease addresses subjects such as Neurology, which are connected to disciplines such as Audiology. His Internal medicine research focuses on subjects like Oncology, which are linked to Biomarker and Positron emission tomography.

His Cognitive decline research entails a greater understanding of Dementia. Anxiety is closely connected to Depression in his research, which is encompassed under the umbrella topic of Cognition. His Amyloid study also includes fields such as

  • Neuroscience which is related to area like Tauopathy,
  • Tau pathology that intertwine with fields like Locus coeruleus.

Between 2018 and 2021, his most popular works were:

  • Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. (300 citations)
  • Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease : A Longitudinal Study (148 citations)
  • Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease : A Longitudinal Study (148 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Alzheimer's disease

His scientific interests lie mostly in Internal medicine, Alzheimer's disease, Dementia, Cognitive decline and Cognition. His study in the fields of Apolipoprotein E, Family history and Amyloid deposition under the domain of Internal medicine overlaps with other disciplines such as Preliminary analysis. Alzheimer's disease is a subfield of Pathology that he studies.

His Dementia study incorporates themes from Temporal lobe, Asymptomatic, Entorhinal cortex, Pediatrics and Tauopathy. His Cognitive decline research includes elements of Alzheimer's Disease Neuroimaging Initiative, Aging brain and Pittsburgh compound B, Amyloid. His Cognition study integrates concerns from other disciplines, such as Disease, Cohort and Depression.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Reisa A. Sperling;Paul S. Aisen;Laurel A. Beckett;David A. Bennett.
Alzheimers & Dementia (2011)

4114 Citations

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease

Randall J. Bateman;Chengjie Xiong;Tammie L.S. Benzinger;Anne M. Fagan.
The New England Journal of Medicine (2012)

2742 Citations

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo.
Alzheimers & Dementia (2018)

2575 Citations

Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease

Randy L. Buckner;Jorge Sepulcre;Tanveer Talukdar;Fenna M. Krienen.
The Journal of Neuroscience (2009)

2452 Citations

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Clifford R. Jack;Marilyn S. Albert;David S. Knopman;Guy M. McKhann.
Alzheimers & Dementia (2011)

1741 Citations

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Stephen Salloway;Reisa Sperling;Nick C. Fox;Kaj Blennow.
The New England Journal of Medicine (2014)

1545 Citations

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

Frank Jessen;Frank Jessen;Rebecca E. Amariglio;Martin van Boxtel;Monique Breteler.
Alzheimers & Dementia (2014)

1285 Citations

Defeating Alzheimer's disease and other dementias: a priority for European science and society

Bengt Winblad;Bengt Winblad;Philippe Amouyel;Sandrine Andrieu;Clive Ballard.
Lancet Neurology (2016)

1131 Citations

Amyloid deposition is associated with impaired default network function in older persons without dementia

Reisa A. Sperling;Reisa A. Sperling;Peter S. LaViolette;Kelly O'Keefe;Jacqueline O'Brien.
Neuron (2009)

919 Citations

The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals

Bradford C. Dickerson;Akram Bakkour;David H. Salat;Eric Feczko.
Cerebral Cortex (2009)

919 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Reisa A. Sperling

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 524

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 473

Philip Scheltens

Philip Scheltens

Vrije Universiteit Amsterdam

Publications: 280

William J. Jagust

William J. Jagust

Helen Wills Neuroscience Institute

Publications: 273

John C. Morris

John C. Morris

Washington University in St. Louis

Publications: 249

Clifford R. Jack

Clifford R. Jack

Mayo Clinic

Publications: 224

Frederik Barkhof

Frederik Barkhof

University College London

Publications: 223

Ronald C. Petersen

Ronald C. Petersen

Mayo Clinic

Publications: 209

Pieter Jelle Visser

Pieter Jelle Visser

Maastricht University

Publications: 201

David A. Bennett

David A. Bennett

Rush University Medical Center

Publications: 196

Giovanni B. Frisoni

Giovanni B. Frisoni

University of Geneva

Publications: 193

David S. Knopman

David S. Knopman

Mayo Clinic

Publications: 184

Victor L. Villemagne

Victor L. Villemagne

University of Pittsburgh

Publications: 178

Rik Ossenkoppele

Rik Ossenkoppele

Lund University

Publications: 174

Wiesje M. van der Flier

Wiesje M. van der Flier

Vrije Universiteit Amsterdam

Publications: 171

Something went wrong. Please try again later.